Sohag University Hospital
Sohag, Egypt
NCT Number: NCT05082818
Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Sohag, Egypt
This study asses the risk factors, prognosis,disease free survival and overall survive rate of treating urinary badder cancer
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Trans urethral resection of the tumour or radical cystectomy
Time frame: 2 weeks after treatment to the time of relapse
Time from the end of treatment to the date of first relapse
Looking for future studies?
Notify MeSohag University
Other
Outcome of Treating Urinary Bladder Cancer in Sohag University Hospital Between 2016 to 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02704832
Adnexal Diseases, Bladder Cancer
Grenoble, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT05858736
Adenocarcinoma, Adnexal Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT02675829
Bladder Cancer, Female Urogenital Diseases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05864144
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial Details